Dr. Shruti K. Gohil is a board-certified UCI Health specialist in infectious diseases who serves as associate medical director for UCI Health Epidemiology and Infection Prevention. Her clinical interests include hospital epidemiology, infection prevention, communicable disease transmission and multidrug resistant organism infections.
She earned her medical degree and a master's in public health from Tufts University School of Medicine in Boston, Mass. She completed an internal medicine residency at the UC Davis School of Medicine, followed by a clinical and research fellowship in infectious diseases at the Albert Einstein School of Medicine in New York City.
Gohil’s research focus is on infection prevention and antibiotic stewardship. She is the lead investigator of four large, randomized and controlled trials to develop a “precision medicine” approach to empiric antibiotic selection. She has led several large-scale epidemiologic studies to evaluate patients' risk for sepsis and hospital readmissions and created a novel scoring system to identify high-risk patients and prevent central line associated bloodstream infections (CLABSIs) in various healthcare settings. She is a member of the Infectious Diseases Society of America and the Society of the Healthcare Epidemiologists in America, serving on the SHEA Research Committee.
In her current administrative role, Gohil leads the UCI Health response to the novel coronavirus pandemic, including the clinical and epidemiologic assessment of healthcare providers and patients, COVID-19 testing and vaccination, exposure definition and response, contact tracing, vaccination and infection prevention strategies to limit viral spread.